Time to redefine the role of routine combined-modality therapy for invasive stage-II/III rectal cancer?

Lily L. Lai, Charles R. Thomas

Research output: Contribution to journalComment/debate

Fingerprint Dive into the research topics of 'Time to redefine the role of routine combined-modality therapy for invasive stage-II/III rectal cancer?'. Together they form a unique fingerprint.